People who were hospitalised with COVID-19 and continued to experience symptoms five months later show limited further recovery one year after hospital discharge, according to the latest results of a major national study looking at the long-term health impacts of COVID-19 on hospitalised patients.
News (all)
Mentoring young scientists at Oxford Health BRC
Oxfordshire young people involved in childline research project
New collection of blogs from the Oxford Health BRC AIMday
Over a third of COVID-19 patients diagnosed with at least one Long-COVID symptom
Youngest children and young people are least willing to get COVID-19 Jab
NIHR launches new race equality in health research framework
Oxford Health takes pioneering step to make research more inclusive
NeurOX YPAG Virtual Work Experience Week 26–30 July 2021
Effect of the COVID-19 Pandemic on Eating Disorders
Ground-breaking treatment offers new hope for patients with persecutory delusions
New Senior Research Fellows named
Academic-Industry Meeting day (AIMday) launches new experimental medicine industry hub
Oxford Health BRC wins government funding for its CHRONOS project
Treating needle fears may reduce COVID-19 vaccine hesitancy rates by 10%
A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia. Strikingly, these individuals were twice as likely to report that they were COVID-19 vaccine hesitant – that is, they would put off getting vaccinated or indeed never get the jab. The study indicates that if all injection anxiety in the population was removed then just over 10% of instances of vaccine hesitancy might disappear too.
COVID-19 and mental health – evidence-based guidance
Celebrating a year of involving young people with research
Living and dying with COVID-19: an ethical perspective is vital
Meet the NIHR Oxford cognitive health Clinical Research Facility
Investigating Neuronal Oscillations in Ageing and Dementia
Some research studies into dementia are starting to use Magnetoencephalography scans (also known as MEG scans) but what is MEG? What does it measure? And what can it tell us about neurodegeneration?
Blog post by Andrew Quinn, Jemma Pitt, Méadhbh Brosnan, Sarah Clayton, & Kia Nobre from the Brain & Cognition lab & OxDARE team for Dementia Action Week 2021.
